Atea Pharmaceuticals AVIR
NASDAQ AVIR
$5.22 +0.04 (+0.68%)
As of: Sep 30, 2026 · 3:59 PM EDT

Atea Pharmaceuticals (AVIR) EV to CFO (2020 - 2021)

Updated

Atea Pharmaceuticals' (AVIR) EV to CFO was 6.75 for Q3 2021, up 93.0% from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) EV to CFO (2020 - 2021) Analysis & Trends

Over the twelve months ended Sep 30, 2021, Atea Pharmaceuticals' EV to CFO came in at -1.40; for FY2020, it was 0.18.

  • Five-year quarterly EV to CFO spans a low of 0.18 in Q4 2020 and a high of 15.03 in Q1 2021.
  • Per Business Quant data, the three quarters before Q3 2021 came in at 3.50 (Q2 2021), 15.03 (Q1 2021) and 0.18 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Atea Pharmaceuticals 415.46 Mn 415.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 6.75
Jun 30, 2021 3.50
Mar 31, 2021 15.03
Dec 31, 2020 0.18
API Access

Atea Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=AVIR&period=max&api_key=YOUR_API_KEY